6 completed, 5 not yet recruiting, 5 recruiting, 3 unknown. 9 Phase 1, 7 Phase 2, 4 Phase 3, 1 Early Phase 1.
Follow Neurodawn Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction Y-6 tablet, Placebo - Perforating Artery Infarction, PAI | Phase 2 / Phase 3 | Not yet recruiting | Neurodawn Pharmaceutical Co., Ltd. | 944 | 2026-08-31 | 2026-07-23 |
| ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea mesalazine, ND-12, ND-12/H-6 - Diarrhea Chronic, UC - Ulcerative Colitis | Early Phase 1 | Recruiting | The Second Hospital of Nanjing Medical University | 36 | 2026-07-20 | 2026-08-17 |
| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants Y-4 tablet, Pregabalin capsule, Riluzole tablet - Healthy Male and Female Subjects | Phase 1 | Not yet recruiting | Neurodawn Pharmaceutical Co., Ltd. | 11 | 2026-06-30 | 2026-06-01 |
| Pharmacokinetic Effect of Y-3 for Injection on Rosuvastatin Calcium Tablets in Healthy Participants Use of rosuvastatin calcium tablet alone or combined with Y-3 for injection - Drug Drug Interaction, Pharmacokinetic Profiles | Phase 1 | Completed | Neurodawn Pharmaceutical Co., Ltd. | 20 | 2026-05-07 | 2026-07-28 |
| Y-4 to Treat the Postherpetic Neuralgia Y-4 tables, Pregabalin - Postherpetic Neuralgia, Y-4 | Phase 2 | Recruiting | Neurodawn Pharmaceutical Co., Ltd. | 160 | 2026-02-02 | 2026-05-13 |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction RK-4 injection - Transcranial Bone Marrow Injection, RK-4 | Phase 1 / Phase 2 | Not yet recruiting | Neurodawn Pharmaceutical Co., Ltd. | 18 | 2025-09-20 | 2025-09-30 |
| Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke Y-6, Y-6 placebo - Stroke | Phase 3 | Not yet recruiting | Beijing Tiantan Hospital | 892 | 2025-08-05 | 2025-06-26 |
| Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects Y-3 for injection（40mg） - Pharmacokinetic Differences, Y-3 | Phase 1 | Not yet recruiting | Neurodawn Pharmaceutical Co., Ltd. | 24 | 2025-07-10 | 2025-07-08 |
| To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects Y-4 tablet - Healthy Male and Female Subjects | Phase 1 | Recruiting | Beijing Tiantan Hospital | 20 | 2025-05-19 | 2025-06-10 |
| Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants sequentially single use of repaglinide, warfarin and omeprazole or combined with Y-3 - Pharmacokinetic Profiles, Y-3 for Injection | Phase 1 | Completed | Neurodawn Pharmaceutical Co., Ltd. | 24 | 2025-05-18 | 2026-05-22 |
| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject Y-4 tablet, Pregabalin capsule, Riluzole tablet - Healthy Male and Female Subjects | Phase 1 | Recruiting | Beijing Tiantan Hospital | 10 | 2025-03-28 | 2025-04-20 |
| A Phase 1 Study of Y-3 in US Healthy Volunteers. Y-3 for injection, Placebo - Safety, Tolerability | Phase 1 | Completed | Neurodawn Pharmaceutical Co., Ltd. | 20 | 2025-02-04 | 2025-12-18 |
| Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects Y-4 tables, Y-4 placebos - Healthy Adult Male and Female Volunteers | Phase 1 | Recruiting | Beijing Tiantan Hospital | 36 | 2025-01-04 | 2025-04-20 |
| Y-3 for Injection in the Treatment of Acute Ischemic Stroke Y-3 for injection, Placebo control group - Acute Ischemic Stroke | Phase 3 | Completed | Beijing Tiantan Hospital | 998 | 2024-07-24 | 2026-07-07 |
| EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual tablets, Low-dose Cilostazol - Acute Ischemic Stroke, Large Vessel Occlusion | Phase 2 | Unknown | Beijing Tiantan Hospital | 300 | 2023-11-01 | 2023-11-18 |
| Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion Y-6 sublingual tablets, Placebo tablets of Y-6 sublingual tablet - Acute Ischemic Stroke, Reperfusion | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-06-05 | 2023-09-28 |
| Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial Y-3 Injection/Y-3 blank injection - Acute Ischemic Stroke | Phase 2 | Completed | Beijing Tiantan Hospital | 240 | 2023-06-04 | 2024-06-04 |
| Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke Minocycline hydrochloride capsule, Placebo capsules of Minocycline hydrochloride capsules - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 1724 | 2023-05-19 | 2025-05-14 |
| Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Sarecycline Tablet, Placebo tablets of Sarecycline tablets - Ischemic Stroke, Acute | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-05-07 | 2023-07-20 |
Ischemic Stroke (7) · Neuralgia, Postherpetic (2) · Stroke (2) · Colitis, Ulcerative (1) · cyclopia sequence (1)
Injections (3) · Pregabalin (3) · Riluzole (2) · Cilostazol (1) · Mesalamine (1) · Minocycline (1) · Omeprazole (1) · Warfarin (1) · sarecycline (1)
China (14) · United States (2)
Yilong Wang, PhD+MD (2) · Yilong Wang, PhD，MD (2) · Shuya Li (1)
PMID 12750546, PMID 19834014, PMID 29232823, PMID 29444972, PMID 29601945, PMID 31263257, PMID 31296369, PMID 31899551, PMID 32414889, PMID 33148815, PMID 34487721, PMID 11306611, PMID 12851164, PMID 19628804, PMID 19837031, PMID 20075087, PMID 21079608, PMID 21102461, PMID 21737808, PMID 21909339, PMID 22632907, PMID 23989795, PMID 24356194, PMID 24685278, PMID 25106063, PMID 25237099, PMID 25274829, PMID 25888869, PMID 26510778, PMID 26898852, PMID 27063107, PMID 27496381, PMID 27673305, PMID 27733282, PMID 28303025, PMID 29367334, PMID 29948247, PMID 30243583, PMID 30296896, PMID 30355104, PMID 30619060, PMID 30646858, PMID 31030188, PMID 31601801, PMID 31610199, PMID 31662037, PMID 31719236, PMID 31991195, PMID 32087818, PMID 32374815